Table of Contents
Table of Contents
Preface
Miscellaneous
Chapter 1. Protease Inhibitors as Potential Antimalarial Agents
Mange Ram Yadav, Mahesh A. Barmade and Prashant R. Murumkar (Faculty of Pharmacy, Kalabhavan Campus, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India)
Chapter 2. Enzymatic Targets for Drug Discovery Against Alzheimer’s Disease
Mahua Basu, S. Balachandran, Nibha Mishra, and Arijit Basu (St. Xavier’s College 30, Mother Teresa Sarani, Kolkata, India, and others)
Chapter 3. Design and Development of Some Selective Enzyme Inhibitors for Parkinson’s and Alzheimer’s Diseases Based on Molecular Modeling and Dynamics Studies
Achintya Saha, Sagar S. Bhayye and Tabassum Hossain (Department of Chemical Technology, University of Calcutta, Kolkata, West Bengal, India)
Chapter 4. Pyruvate Dehydrogenase Kinases (PDHKs) and Their Inhibition: A Possible Line of Treatment for Diabetes, Heart Ischemia and Cancer
Rita Kakkar and Mamta Bhandari (Computational Chemistry Group, Department of Chemistry, University of Delhi, Delhi, India)
Chapter 5. Advances in Studies on COX/LOX Enzymes Inhibitors as Drugs
Pontiki Eleni and Hadjipavlou-Litina Dimitra (Department of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece)
Chapter 6. Design and Development of Matrix Metalloproteinase Inhibitors Containing Zinc-Binding Groups, without Zinc-Binding Groups, and Mechanism-Based
Nilanjan Adhikari, Sandip Kumar Baidyaa, Achintya Saha, Nahid Ali, and Tarun Jha (Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India, and others)
Chapter 7. Computational Study of D-Amino Acid Oxidase and Its Inhibitors
Kiattisak Lugsanangarm, Kanin Wichapong, Nadtanet Nunthaboot, Arthit Nueangaudom, Somsak Pianwanit, Fumio Tanaka, and Sirirat Kokpol (Program of Chemistry, Faculty of Science and Technology, Bansomdej Chaopraya Rajabhat University, Bangkok, Thailand, and others)
Chapter 8. Cytochrome P450 Inhibitors Used as Drugs
Dolly A. Parasrampuria (Clinical Pharmacology & Pharmacometrics, Janssen Research & Development, LLC, Titusville, New Jersey, United States of America)
Chapter 9. Quantum Chemical Insights into Metabolic Inhibition of Cytochrome P450 Enzymes: Piperine, Curcumin, and Metal Complexes of Curcumin: Promises and Bioavailability
Krishnan Balasubramanian (School of Molecular Sciences, Arizona State University, Tempe, Arizona, United States of America)
Chapter 10. Design and Development of Angiotensin-Converting Enzyme Inhibitors
Satish B. Bhise (KLK Consultants, Navkar Residency, Behind Bibvewadi Police Station, Bibvewadi, Pune, Maharashtra, India)
About the Editor
Index
